Get started
Author

Felicitas Müller

Observed name: F. MÜLLER
Institution: BioNTech (Germany)
OpenAlex ID: A5061352303
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
2017 · Ugur Sahin, Evelyna Derhovanessian, et al. · Nature · 2,546
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
2023 · Luis A. Rojas, Zachary Sethna, et al. · Nature · 1,511
PDF
Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo
2009 · Felicitas Müller, Nicola J. Mutch, et al. · Cell · 848
PDF
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
2025 · Zachary Sethna, Pablo Guasp, et al. · Nature · 367
Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type III
2006 · Sven Cichon, Ludovic Martin, et al. · The American Journal of Human Genetics · 331
PDF
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
2025 · Juanita Lopez, Thomas Powles, et al. · Nature Medicine · 131
PDF
Factor XI and XII as antithrombotic targets
2011 · Felicitas Müller, David Gailani, et al. · Current Opinion in Hematology · 120
Novel roles for factor XII-driven plasma contact activation system
2008 · Felicitas Müller, Thomas Renné · Current Opinion in Hematology · 102
Unrip, a factor implicated in cap-independent translation, associates with the cytosolic SMN complex and influences its intracellular localization
2005 · Matthias Grimmler, Simon Otter, et al. · Human Molecular Genetics · 89
Factor XI deficiency in animal models
2009 · T. RENNÉ, C. OSCHATZ, et al. · Journal of Thrombosis and Haemostasis · 61
PDF
Platelet polyphosphates: The nexus of primary and secondary hemostasis
2011 · Felicitas Müller, Thomas Renné · Scandinavian Journal of Clinical and Laboratory Investigation · 38
Abstract CT169: A phase Ia study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in patients with locally advanced or metastatic solid tumors
2020 · Fadi Braiteh, Patricia LoRusso, et al. · Cancer Research · 35
Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
2018 · Robert A. Jabulowsky, Carmen Loquai, et al. · Cancer Research · 12
Abstract PR-06: Personalized RNA neoantigen vaccines induce long-lived CD8+ T effector cells in pancreatic cancer
2024 · Pablo Guasp, Zachary Sethna, et al. · Cancer Immunology Research · 5
Works count: 14
Citation count: 6,196
H-index: 12
I10-index: 13
Year
Topic
Type